Literature DB >> 18926716

Nerve-sparing radical hysterectomy for cervical carcinoma.

Polat Dursun1, Ali Ayhan, Esra Kuscu.   

Abstract

With the concept of the improvement of quality of life in the field of surgical oncology, recent studies have questioned the place of radical hysterectomy (RH) in the treatment of cervical carcinoma due to a high rate of long-term postoperative complications involving the pelvic autonomic nerve system. It has been demonstrated that RH frequently causes bladder dysfunction, anorectal mobility disorders, and sexual dissatisfaction in cervical cancer survivors due to surgical trauma involving the sympathetic and parasympathetic branches of the autonomous innervation of the pelvic organs. Nerve-sparing RH was first pioneered by Takashi Kobayashi in Japan and then other Japanese gynecologic surgeons introduced and improved this concept to Western countries. However, nerve-sparing RH has only become popular among gynecologic surgeons during the last two decades. Recently, European gynecologic surgeons modified this concept. Herein, a review of the evolution of nerve-sparing RH, a quick overview of long-term pelvic organ dysfunctions associated with RH, and the technical details of different authors and their oncological outcomes are presented. Today, the lack of randomized studies comparing the effectiveness and complications of RH with nerve-sparing RH is an important barrier to the widespread use of this concept. Nonetheless, while nerve-sparing RH still awaits prospective randomized trials in order to prove that its effectiveness is equal to or greater than that of conventional treatment modalities, and that is has fewer long-term complications, this surgical approach remains attractive for the patients and gynecologic oncologists based on the published results.

Entities:  

Mesh:

Year:  2008        PMID: 18926716     DOI: 10.1016/j.critrevonc.2008.09.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  5 in total

1.  Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery.

Authors:  Fabio Castiglione; Alice Bergamini; Arianna Bettiga; Trinity J Bivalacqua; Fabio Benigni; Frank Strittmatter; Giorgio Gandaglia; Patrizio Rigatti; Francesco Montorsi; Petter Hedlund
Journal:  Eur Urol       Date:  2012-04-19       Impact factor: 20.096

2.  Postoperative Health-Related Quality of Life of Cervical Cancer Patients - A Comparison between the Wertheim-Meigs Operation and Total Mesometrial Resection (TMMR).

Authors:  E Sowa; S Kuhnt; A Hinz; C Schröder; T Deutsch; K Geue
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-07       Impact factor: 2.915

Review 3.  Vaginal drug delivery for the localised treatment of cervical cancer.

Authors:  Ian Major; Christopher McConville
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.

Authors:  Giovanna Mantegna; Marco Petrillo; Gilda Fuoco; Laura Venditti; Serena Terzano; Luigi Pedone Anchora; Giovanni Scambia; Gabriella Ferrandina
Journal:  BMC Cancer       Date:  2013-03-18       Impact factor: 4.430

5.  Acupuncture for preventing complications after radical hysterectomy: a randomized controlled clinical trial.

Authors:  Wei-Min Yi; Qing Chen; Chang-Hao Liu; Jia-Yun Hou; Liu-Dan Chen; Wei-Kang Wu
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-15       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.